An abnormally low concentration of serum gamma globulin occurs in association with a wide variety of clinical conditions (1, 2) . This reduction in serum gamma-globulin concentration may be the result of decreased synthesis or of increased catabolism or loss. Hypogammaglobulinemia due to decreased synthesis (hyposynthetic) has been classified into four groups (2): 1) Physiological hypogammaglobulinemia, a condition occurring during the first year of life when the gamma globulin derived from the mother is catabolized before synthesis by the infant becomes adequate to maintain normal serum concentrations; 2) congenital hypogammaglobulinemia, a hereditary, sex-linked trait resulting in an extreme defect in gamma-globulin synthesis; 3) acquired hypoganimaglobulinemiia secondary to neoplastic disease, a disorder that occurs with neoplasms that affect the plasma cells, such as thymoma, chronic lymphocytic leukemia, Hodgkin's disease, and multiple myeloma; and 4) idiopathic acquired hypogammaglobulinemia. Many of the patients in groups 2, 3, and 4 have recurrent infections and associated chronic sinusitis, bronchiectasis, arthritis, and unexplained gastrointestinal tract disorders resembling sprue or ileocolitis (3, 4) .
Hypogammaglobulinemia due to increased catabolism or loss (hypercatabolic) occurs in association with nephrosis (5) and protein-losing gastroenteropathy (6, 7) . Certain features aid in differentiating hyposynthetic from hypercatabolic hypogammaglobulinemia. Patients with impaired synthesis have a much greater incidence of bacterial and fungal infections; have markedly reduced ability to synthesize specific antibodies in response to antigenic challenge; have negligible isohemagglutinin titers; and have a decrease or absence of plasma cells in the bone marrow, lymph nodes, and intestinal tract (1, 2, 8, 9 ). In contrast, patients who have hypercatabolic hypogammaglobulinemia as their primary disorder have normal or only slightly reduced isohemagglutinin titers; have normal ability to synthesize antibodies; and have normal numbers of plasma cells (8) (9) (10) . By using I131-labeled gamma globulin to determine directly the turnover (synthetic rate) of gamma globulin, one finds rates approximately 10% of normal in the patients with impaired synthesis, whereas those with hypercatabolism have rates equal to or twice normal (6) .
Until recently little attention has been directed toward the metabolism of proteins other than gamma globulin in patients with hyposynthetic hypogammaglobulinemia. In the present study the serum albumin concentration was determined in 24 patients with impaired synthesis of gamma globulin. Twenty of these patients had significant hypoalbuminemia. Six were studied by using I'1"-labeled albumin to measure the circulating and total body albumin pools as well as the rates of albumin degradation and synthesis. I131-labeled polyvinylpyrrolidone (PVP) was used to determine whether excessive gastrointestinal protein loss was present. In addition, the effect of therapy on the abnormalities of albumin metabolism was studied. A brief summary of this study has been presented previously (11) .
Methods
The 24 patients included in this study entered the Clinical Center of the National Institutes of Health with serum gamma-globulin concentrations of 400 mg per 100 ml or less. That their hypogammaglobulinemia was attributable to defective synthesis was shown by various techniques. They all had isohemagglutinin titers of 1: 4, or less, whereas the lower limit of the normal range is 1: 32 (8) . Antibody production in response to administration of exogenous antigens was markedly depressed in each of the 12 patients studied. The rate of gamma-globulin synthesis, studied with 1131 gamma globulin, was 0.001 to 1025 0.008 g per kg per day in the 15 patients studied, whereas the range in normal control subjects was 0.03 to 0.05 g per kg per day. Twenty-two patients had either an P"3 gamma-globulin study or a study of response to exogenous antigens, or both. The patients' ages ranged from 11 to 64 years. Eight had congenital hypogammaglobulinemia, 11 had idiopathic acquired hypogammaglobulinemia, and five had hypogammaglobulinemia secondary to neoplasia (one with Hodgkin's disease, three with chronic lymphocytic leukemia, and one with thymoma). Twenty-one of the 24 patients had a history of recurrent bacterial infections, and of the 21, 20 had recurrent pneumonia, 18 had bronchiectasis, and 16 had sinusitis. Five of the 24 had arthritis, and 12 had significant diarrhea or steatorrhea. Of these 12, five had chronic Salmonella or Shigella infections, two had giardiasis, and five had no detectable enteric pathogens.
Six of the 24 patients were selected for detailed studies of their albumin metabolism. Groups 2, 3, and 4 of the types of hyposynthetic hypogammaglobulinemia described in the introduction were represented. Significant clinical features of these patients are summarized in Table I and in the appendix to this paper.
Total serum protein concentration was determined by a biuret method (12) , and the albumin and gamma-globulin concentrations were determined by paper electrophoresis with a pH 8.6 barbital buffer (13) . Xylosetolerance tests were carried out according to Benson and associates (14) , using the Roe and Rice assay method (15) . Serum carotenoids were assayed according to Carr and Price (16) . Stool fat determinations were made on 3-day pools by the method of van de Kamer (17) . Intestinal biopsies were performed with the instrument described by Brandborg, Rubin, and Quinton (18).
Metabolism of P'31-labeled proteins I" albumin (Risa T')1 was used to determine albumin turnover. The techniques for the preparation and labeling of gamma globulin are described elsewhere (7) . The gamma globulin was isolated from normal serum by curtain electrophoresis and was then labeled with I', using the iodine monochloride method of McFarlane (19) .
Thyroidal uptake of IJ3" released by breakdown of the labeled albumin was inhibited by the administration of 0. (This fraction is determined after completion of the equilibration of I... albumin among the body compartments, after days 6 to 8); and total body albumin pool = total circulating albumin/fraction body albumin intravascular.
II. Albumin degradation and turnover
These values were obtained by two methods: method A, which depends on the rate of decline of whole body radioactivity, and method B, which depends on the daily relationship between urinary radioactivity and circulating radioactivity.
Method A. A semilogarithmic plot of the radioactivity retained in the body with time was used to determine the survival half-time of I"~albumin, ti. Then, fraction of body albumin degraded per day = 0.693/ti in days, and albumin turnover = total body albumin pool X fraction 'of body albumin degraded per day.
Method B. Fraction of circulating albumin degraded per day = urinary radioactivity per 24-hour period/mean circulating radioactivity during the same period. This fraction was determined for each collection period, and the mean value for the different periods was used in the following calculation. Albumin turnover = total circulating albumin X fraction of circulating albumin degraded per day.
As shown in Table II ml all had significant gastrointestinal symptoms. The mean serum albumin concentration of the 12 patients with gastrointestinal tract disorders was 2.5 g per 100 ml compared to 3.5 g per 100 ml in the remaining 12 patients.
Protein turnover studies. Six patients were selected for studies of their albumin metabolism. All had diarrhea (Figure 1 ). The hypogammaglobulinemia was congenital in M.Q., secondary to neoplasm in E.R., and idiopathic. acquired in the remaining four patients.
The results of the I131 albumin and the 1131 PVP studies are presented in Figure 2 and Table  II . The values for both the total circulating albumin and the total body albumin pool were reduced in each of the patients before treatment. This indicated that the reduced serum albumin concentrations were due to a deficiency of albumin and not Both impaired synthesis of albumin and excessive loss into the gastrointestinal tract were responsible for the hypoalbuminemia of patient M.Q., since the albumin synthetic rate was 0.11 g per kg per day, the t4 of albumin survival was 7.2 days, and excessive I131 PVP appeared in the stools.
Results of therapy. I.T., who had malabsorption and chronic intestinal infection with Salmonella newport in association with his hypogammaglobulinemia, was treated with a gluten-free diet and broad-spectrum antibiotics. After therapy, his stool cultures became negative and his malabsorption decreased markedly (Table I) . His serum albumin concentration, the half-time of survival of iodinated albumin, and the fecal excretion of I131 PVP returned to normal, indicating a reversal of the previous excessive loss of albumin into the gastrointestinal tract ( Figure 2 and Table II ). His serum gamma-globulin concentration remained depressed, and the gamma-globulin synthetic rate following treatment was approximately 10% of normal (Table II) , indicating that the primary defects in the plasma cells and in gamma-globulin production had not been affected by therapy.
Treatment of patient P.M. with a gluten-free diet was followed by an increase in her serum albumin concentration and a return to normal of "131 albumin survival and of I131L PVP excretion. Her serum gamma-globulin concentration and the rate of gamma-globulin synthesis remained exceedingly low.
M.Q., with congenital hypogammaglobulinemia and associated ileocolitis, was treated with ACTH and then with prednisone. After therapy, the serum albumin concentration, albumin survival, albumin synthetic rate, and 1131 PVP excretion returned toward normal. Again the gamma-globulin concentration and the gamma-globulin synthetic rate remained low after therapy.
Discussion
The present study has revealed a reduction in serum albumin concentration in a majority of 24 patients with all three pathological forms of defective gamma-globulin synthesis. The hypoalbuminemia was most marked in those patients with gastrointestinal symptoms. In the six cases where the metabolism of albumin was studied with I131 albumin and I131 PVP, three had diminished albumin synthesis as the major factor in their hypoalbuminemia, two had excessive enteric loss of protein, and one had both diminished albumin synthesis and excessive enteric loss.
Several observations concerning albumin synthesis in these patients deserve discussion. Although the calculated values for albumin synthesis for I.T. and P.M. were not below the lower limit of the normal range, nevertheless, these patients may be regarded as showing a relative defect in albumin synthesis because they were apparently unable to accelerate their synthetic rates in response to the stimulus of hypoalbuminemia. Patients with idiopathic pathological enteric albumin loss have increased their synthetic rates up to values as high as 0.4 g per kg per day in response to hypoalbuminemia comparable, in degree, to that of I.T. and P.M. (23) . Thus, all six patients in the present study had defective albumin synthesis, either absolute or relative. According to current knowledge, a defect in albumin synthesis is not a logical consequence of defective synthesis of gamma globulin. Gamma globulin is produced in plasma cells, and its synthesis was depressed in our patients as a result of either a decrease in the number of plasma cells or a qualitative impairment of the synthetic capacity of plasma cells. Albumin, however, is produced in the liver. Why, then, was its synthesis impaired? Liver damage or lack of albumin precursors, due either to deficient intake or to malabsorption, are two possible explanations.
Liver damage does not appear to be a major factor, since liver function tests were essentially normal in all six patients when their albumin metabolism was studied (Table I) . A reduced intake of calories and amino acids, or malabsorption, may have played a significant role in the defective albumin synthesis, since the six patients had steatorrhea. Four had weight loss before this study, and all but one were underweight. Finally, other as yet undefined factors may be responsible for the defective albumin synthesis of the patients studied, since defective albumin synthesis is a common feature of chronic inflammatory diseases even when evidence of malabsorption or liver damage is lacking (24, 25) .
Minor loss of protein into the gastrointestinal tract occurs in normal subjects and appears to be a factor in the normal catabolism of the serum proteins (26) . Excessive enteric protein loss has been shown to be of significance in the hypoalbuminemia associated with a variety of disorders, including Whipple's intestinal lipodystrophy (27) , gastric rugal hypertrophy (28), gastric carcinoma (29) , sprue (30) , regional enteritis, ulcerative colitis (31), constrictive pericarditis (32), and intestinal lymphangiectasia (6, 23). Holman, Nickel, and Sleisenger (6) described a patient with hypogammaglobulinemia, excessive enteric protein loss, and a localized granulomatous lesion of the small bowel. After resection of this lesion, the abnormal gastrointestinal protein loss stopped, but the serum gamma-globulin concentration fell to an even lower level. Vesin and co-workers (33) described a patient with hypogammaglobulinemia, protein-losing gastroenteropathy, and malabsorption, who responded to treatment with a gluten-free diet with reversal of the steatorrhea and hypoalbuminemia, but with persistence of the extreme hypogammaglobulinemia. In the present study, three of the six patients had gastrointestinal protein loss as a major factor in their hypoalbuminemia as demonstrated by the use of 1131 albumin and I13l PVP. One of these three patients had unexplained diarrhea and steatorrhea (P.M.), one had ileocolitis (M.Q.), and the third had chronic salmonellosis (I.T.). In each case appropriate therapy resulted in reversal of the abnormal enteric protein loss and of the hypoalbuminemia (Table II) . However, the hypogammaglobulinemia and the defect in gammaglobulin synthesis persisted.
The pathological physiology. in these patients appears to be a primary disturbance of plasma cell development or function with a consequent defect in the synthesis of gamma globulins that leads to disorders of the gastrointestinal tract and consequent excessive enteric protein loss and hypoalbuminemia. This entity should be distinguished from excessive enteric protein loss due to primary bowel disease in which the hypoalbuminemia and the hypogammaglobulinemia are due solely to the exudative enteropathy, but in which the synthesis of gamma globulin is normal. In the latter entity, reversal of the abnormal enteric protein loss restores the serum concentrations of both albumin and gamma globulin to normal (10) .
The ability to differentiate those patients with hyposynthetic hypogammaglobulinemia whose hypoalbuminemia is due to excessive enteric loss from those whose hypoalbuminemia is due to impaired synthesis of albumin is clinically important, since excessive loss may be reversed by appropriate therapy. This was demonstrated in the cases reported by Holman and co-workers (6) and Vesin and associates (33) and in the three cases described in the present paper. Unfortunately, the differentiation cannot be made on the basis of routine clinical studies. All six of the patients described in the present study, both those with excessive gastrointestinal albumin loss and those with defective albumin synthesis, had a low or low-normal serum cholesterol concentration, essentially normal liver function studies, significant diarrhea, and variable steatorrhea. Two patients from both the enteric loss and defective albumin synthesis groups had abnormalities of the X-ray examination of the intestine, ranging from coarsening of the mucosal folds, interpreted as mucosal edema, to significant ulceration of the ileocecal mucosa. Peroral biopsy of the jejunal muticosa showed abnormalities in patients in each of the groups. Thus, to detect those patients with hyposynthetic hypogammaglobulinemia and associated excessive intestinal protein loss, one must use techniques such as the I131 albumin and IJ3" PVP tests that directly measure the metabolism of the proteins.
The reason for the 20 to 50% incidence of gastrointestinal tract disturbances in patients with impaired synthesis of gamma globulins is not entirely clear. Undoubtedly, in a certain number of these patients antibody deficiency predisposes them to enteric infections which are the immediate causes of the gastrointestinal tract pathology. This was true in six of the 12 patients with gastrointestinal disorders in the present study. I.T., who had enteric infection with Salmonella newport, is a typical example of this problem. Other patients, however, such as M.Q., whose clinical picture was that of ileocolitis, and A. J., who had features possibly suggestive of sprue, do not have problems obviously attributable to infection. In considering possible explanations for these disorders, we note that patients with hypogammaglobulinemia are also prone to chronic sinusitis and bronchitis, inflammations of other mucosal barriers to the external environment. This apparent general vulnerability of mucosal surfaces may in some way be related to the reduction in ability to form antibodies and to the absence of plasma cells from these tissues. Summary 1) The serum albumin concentration was determined in 24 patients with defective gamma-globulin synthesis, including groups with congenital hypogammaglobulinemia, idiopathic acquired hypogammaglobulinemia, and hypogammaglobulinemia secondary to neoplastic disease.
2) The serum albumin concentration was below the lower limit of normal of 3.6 g per 100 ml in 20 of the 24 patients.
3) Each of the eight patients wjth a serum albumin concentration below 3 g per 100 ml had significant gastrointestinal symptoms.
4) The albumin metabolism of six of the patients with hypoalbuminemia and diarrhea was studied with I131-labeled albumin and 1131-labeled polyvinylpyrrolidone.
5) The total body albumin pool was reduced in each of these patients. In four of the patients there was defective albumin synthesis, and in two of the patients the albumin synthetic rate was within normal range.
6) In three of the patients excessive loss of albumin into the gastrointestinal tract was a significant factor in the hypoalbuminemia. After treatment of these patients with antibiotics, gluten-free diet, or corticosteroids, there was a marked diminution in, or complete cessation of the abnormal enteric loss of albumin, with a return to normal serum and total body albumin levels. However, the primary defect in gamma-globulin synthesis was not affected by the therapy.
7) It is felt that the primary disorder in all these patients is defective gamma-globulin synthesis. However, an associated secondary disorder of the intestinal mucosa may be seen with consequent general enteric loss of the serum proteins.
opsies from the proximal jejunum revealed short, broad villi and plasma cell infiltration of the lamina propria. The intestinal pathology in this and in the following cases will be described in detail elsewhere (34 Xylose-tolerance test results and serum carotenoid concentration were normal. Roentgen study revealed small bowel mucosal edema.
On admission, he was debilitated and had emphysema, with coarse, sticky rales in the left lower lobe, and a liver edge three finger-breadths below the right costal margin. The leukocyte count varied between 3,500 and 7,600 cells per mm3. Agglutination studies for Salmonella were negative. A jejunal mucosal biopsy revealed short, wide villi, consistent with partial atrophy, and hypocellularity of the lamina propria with virtual absence of plasma cells. Bone marrow aspiration showed myeloid hypoplasia and no plasma cells.
He developed recurrent septicemias and pulmonary infections and severe watery diarrhea, with malabsorption, weight loss, and peripheral edema. Salmonella newport was isolated from his stools and Escherichia coli from his blood. Treatment with gamma globulin and several broad spectrum antibiotics and a gluten-free diet failed to improve him. After intramuscular administration of colistimethate sodium (Coly-Mycin), his blood became sterile, the Salmonella disappeared from his stools, his diarrhea and edema subsided, and his weight rose from 40 to 62 kg. All tests of intestinal absorption (except for the Schilling and xylose-tolerance tests), the roentgen appearance of the small intestine, and the morphological abnormalities of the jejunal mUcosa, with the exception of the absence of plasma cells, returned toward normal.
Patient P.MI.-hypogammaglobuIinenzia; chronic lung disease; intermittent malabsorption. This 35-year-old white housewife entered in January 1960, with hypogammaglobulinemia. Starting at age 16 she had numerous ear and lung infections, and at age 22 she had a left lower lobectomy. At age 26 she developed recurrent episodes of severe diarrhea with foul, green, fatty stools. At age 29 her hypogammaglobulinemia was detected. No plasma cells were seen in her bone marrow, her oral glucose tolerance test suggested poor absorption, and roentgen studies revealed coarsened mucosal folds in the small intestine and extremely rapid transit of contrast material. She improved after receiving antibiotics, cortisone, and gamma globulin, remained relatively well until age 31 when her pulmonary symptoms returned, and again responded to treatment. Her diarrhea, however, recurred and persisted.
On admission she was thin and chronically ill, and had diffuse expiratory wheezing, a distended abdomen, and no peripheral edema. Roentgen studies revealed emphysema, chronic fibrocystic disease of the lungs, and hepatosplenomegaly, but no abnormalities of the upper gastrointestinal tract. The jejunal mucosa contained almost no plasma cells.
On February 18, 1960, she developed an Escherichia coli urinary tract infection and was treated with 2 g of tetracycline daily by mouth. On February 21, she was placed on a gluten-free diet. By February 29, her diarrhea had subsided, and it did not return. After her discharge in March she remained on a gluten-free diet for several months and then changed to a normal diet, but Starting at age 1, after a perianal infection, he had numerous infections of the ears, nose, throat, lungs, and skin and episodes of hip and elbow arthritis. At age 7, hypogammaglobulinemia was detected and treated with periodic gamma-globulin injections. Because of recurrent sinusitis and lung infections he received tetracycline from age 9 to 11i and did well. Then a rectal abscess was incised and drained, and penicillin was substituted for tetracycline. A week later he developed crampy abdominal pain and diarrhea. No pathogenic bacteria or parasites were found in the stools. His rectal mucosa appeared edematous and inflamed, but a biopsy was interpreted as normal. He responded to blood transfusions, ACTH, and steroids by rectum and remained relatively well until age 12 when the diarrhea and abdominal pain recurred and he lost 14 pounds.
On admission, his height and weight were strikingly below normal, he had thickened ear drums, scattered pulmonary rales and rhonchi, and perirectal tabs. His leukocyte count'was 15,000 per mm3. Roentgen studies revealed extensive bronchiectasis, coarse mucosal folds in the entire small intestine, fixation of several ileal loops, and an area of constant narrowing near the large intestine's splenic flexure, with mucosal spiculation in the narrowed area. Jejunal and rectal mucosal biopsies and bone marrow aspiration were abnormal only for the absence of plasma cells.
Because of progressive weight loss, fever, increasing diarrhea, rapid decline in serum albumin and cholesterol concentrations, and progressive anemia, he received blood transfusions, ACTH intravenously, and prednisolone, and he improved generally and significantly. The area of large-bowel narrowing also disappeared.
